LifeScan (US) and Novo Nordisk (Denmark) managing diabetes together
This article was originally published in Clinica
Novo Nordisk (Denmark) and LifeScan (US) have signed a joint marketing deal to provide a total diabetes management service. The two companies will work together to market their complementary product lines - Novo's insulin and LifeScan's blood glucose monitoring systems. Johnson & Johnson subsidiary LifeScan sees the agreement as an opportunity to market its One Touch systems in international markets, particularly Europe and Japan.